To diagnose diabetes, prediabetes, and gestational diabetes, your healthcare provider performs blood tests to measure blood glucose levels and determine the type of diabetes.
Avoid self-diagnosing diabetes with unreliable equipment that may not give an accurate diagnosis.
It is important to follow your healthcare provider’s recommendations for diabetes testing, as early diagnosis and treatment can help manage the condition effectively and reduce the risk of complications.
Regular monitoring of blood glucose levels is essential for individuals with diabetes, as it helps in maintaining proper blood sugar control and adjusting treatment plans as needed.
Who should be tested for diabetes?
Testing is recommended for individuals experiencing diabetes symptoms, those at high risk for type 2 diabetes, and most pregnant women to check for gestational diabetes.
Medicare coverage may include testing expenses for individuals with specific diabetes risk factors.
Blood tests are essential for the accurate diagnosis of diabetes and prediabetes.
Type 1 diabetes
Diagnosing type 1 diabetes in children and young adults is based on symptoms such as increased thirst, frequent urination, and diabetic ketoacidosis. Family history can also play a role in type 1 diabetes diagnosis.
Type 2 diabetes
Routine testing is recommended for type 2 diabetes if specific risk factors are present, including age, ethnicity, or a history of gestational diabetes. Children and teens at risk for type 2 diabetes should also undergo testing.
Regular follow-up testing is advised for those with normal test results.
Testing for type 2 diabetes before and during pregnancy
Women planning pregnancy should be tested for type 2 diabetes, and pregnant women should undergo early pregnancy testing to prevent complications.
Gestational diabetes
Pregnant women should be tested for gestational diabetes between 24 and 28 weeks of pregnancy and receive postpartum testing for type 2 diabetes if gestational diabetes was present.
What tests are used to diagnose diabetes?
Various tests, including fasting plasma glucose, A1C, random plasma glucose, oral glucose tolerance, and glucose challenge tests, are used by healthcare providers to diagnose diabetes based on symptoms and risk factors.
Fasting plasma glucose test
Fasting plasma glucose test measures blood glucose levels after an 8-hour fast to establish a baseline for diabetes diagnosis.
A1C test
The A1C test provides average blood glucose levels over 3 months and is used to diagnose diabetes while considering factors that may affect test accuracy. Results are presented as a percentage indicating average blood glucose levels.
Random plasma glucose test
Random plasma glucose tests are used for immediate diabetes diagnosis without fasting requirements when symptoms are present.
Glucose challenge test
Pregnant women may undergo the glucose challenge test for gestational diabetes, followed by an oral glucose tolerance test if glucose levels are elevated.
Oral glucose tolerance test
The oral glucose tolerance test aids in more accurate diabetes type detection but can be costly and requires fasting before testing.
Tests for diagnosing diabetes and prediabetes
Common tests for diagnosing diabetes and prediabetes include:
- Fasting Plasma Glucose Test: A fasting plasma glucose test measures blood sugar levels after fasting for at least 8 hours. Results <150 mg/dL indicate normal blood sugar levels, 100-125 mg/dL suggest prediabetes, and >126 mg/dL may indicate diabetes.
- Oral Glucose Tolerance Test: This test involves drinking a glucose solution, then having blood sugar levels checked after 2 hours. Results <140 mg/dL are normal, 140-199 mg/dL suggest prediabetes, and >200 mg/dL may indicate diabetes.
- HbA1c Test: The HbA1c test measures average blood sugar levels over the past 2-3 months. Results <5.7% are normal, 5.7-6.4% suggest prediabetes, and >6.5% may indicate diabetes.
It’s essential to consult with a healthcare provider to interpret test results accurately and discuss appropriate next steps for managing diabetes or prediabetes. Early detection and management are crucial for preventing complications associated with diabetes.
C-peptide test
A C-peptide test measures the level of this protein in the blood, which can help distinguish between type 1 and type 2 diabetes. Low levels of C-peptide may indicate type 1 diabetes, while high levels may indicate type 2 diabetes.
GAD antibody test
The GAD antibody test checks for the presence of glutamic acid decarboxylase (GAD) antibodies, which are often found in individuals with type 1 diabetes. This test can help confirm a diagnosis of type 1 diabetes in those who have already been diagnosed with diabetes.
HbA1c test
The HbA1c test measures average blood glucose levels over the past 2-3 months, providing information about long-term blood sugar control. This test is used to diagnose type 2 diabetes and monitor treatment progress in both type 1 and type 2 diabetes.
By utilizing these tests in combination, healthcare providers can accurately diagnose and differentiate between the various types of diabetes, allowing for personalized treatment plans tailored to each individual’s specific needs.
Reference
Reference: American Diabetes Association Professional Practice Committee. Standards of medical care in diabetes—2022. Diabetes Care. 2022;45(suppl 1):1–16.7
Content provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. NIDDK aims to increase knowledge about health and disease by translating and disseminating research. Expert-reviewed content produced by NIDDK.
The NIDDK acknowledges Randy Little, Ph.D., University of Missouri.
Diabetes mellitus results from either deficient insulin secretion (type 1) or peripheral insulin resistance (type 2), causing hyperglycemia. Common early symptoms include increased thirst, frequent urination, weight loss, and excessive hunger. Diagnosis involves measuring plasma glucose levels, with treatment comprising medications, diet, and exercise.
Children’s diabetes mellitus types mirror those in adults but can be complicated by psychosocial factors.
It is crucial for parents and caregivers to educate themselves about managing diabetes in children and adolescents. Monitoring blood sugar levels regularly, administering insulin or other medications as prescribed, following a healthy diet, and encouraging physical activity are all key components of diabetes management in this age group.
In addition to medical management, emotional support and open communication are essential for children and adolescents dealing with diabetes. Psychosocial factors such as stress, anxiety, and peer pressure can impact diabetes management, making it important for healthcare providers, parents, and school personnel to work together to support young patients.
Types of Diabetes in Children and Adolescents
Type 1 diabetes is predominant in children, accounting for the majority of new cases in children of all racial and ethnic backgrounds. This chronic childhood disease is typically diagnosed between ages 4-6 and 10-14, with a rising global incidence, particularly in children aged 10-19.
Type 2 diabetes, once rare in children, has become more common with the increase in childhood obesity. Approximately 80% of children with type 2 diabetes are obese, yet the relationship is complex and varies.
Monogenic diabetes forms are distinct from type 1 or type 2 and are not widespread.
Prediabetes is linked to the metabolic syndrome.
Types references
Resources on diabetes epidemiology and trends.
Etiology of Diabetes in Children and Adolescents
Type 1 and type 2 diabetes have diverse causes and treatment strategies. Some patients may not fit neatly into either type 1 or type 2 diabetes categories.
Type 1 diabetes
In type 1 diabetes, minimal to no insulin is produced due to the immune system attacking pancreatic beta-cells. Genetic factors contribute to type 1 diabetes susceptibility, and children with type 1 diabetes are at heightened risk of other autoimmune conditions.
Type 2 diabetes
Type 2 diabetes involves varying levels of insulin resistance leading to relative insulin deficiency, often coinciding with pubertal insulin resistance.
Monogenic diabetes
Monogenic diabetes forms stem from genetic defects with an autosomal dominant inheritance pattern.
Etiology references
Resources on the genetics of diabetes.
Pathophysiology of Diabetes in Children and Adolescents
In type 1 diabetes, hyperglycemia and ketoacidosis result from insulin deficiency.
In type 2 diabetes, children may present with diabetic ketoacidosis or hyperosmolar state at diagnosis. Metabolic abnormalities associated with insulin resistance may also be present.
Dyslipidemia leading to atherosclerosis is common, initiating in childhood or adolescence and significantly increasing the risk of cardiovascular disease.
In monogenic diabetes forms, defects can vary, with common types linked to issues with beta-cell function-regulating transcription factors. Diabetic ketoacidosis can manifest in children with type 2 diabetes.
Symptoms and Signs of Diabetes in Children and Adolescents
Symptoms of type 1 diabetes can span from asymptomatic hyperglycemia to diabetic ketoacidosis. Approximately half of children with type 1 diabetes experience weight loss. Initial symptoms may include fatigue, weakness, rashes, blurred vision, and nausea.
Type 2 diabetes can exhibit a wide range of presentations.
Diagnosis of Diabetes in Children and Adolescents
Diagnosing diabetes in children aligns with adult diagnostic criteria, including fasting or random plasma glucose levels and/or HbA1C levels. Oral glucose tolerance testing may also be utilized, with additional tests necessary for distinguishing between diabetes types.
Diagnosis of diabetes in children
Initial tests for suspected diabetes include basic metabolic panel and urinalysis. Ill patients may require additional tests like blood gas, liver function tests, and electrolyte assessments.
Initial evaluation
Further tests are essential for differentiating between diabetes types. Testing for autoantibodies is crucial in diagnosing type 1 diabetes, while patients with type 2 diabetes should undergo additional testing for complications.
Evaluation for diabetes type and stage
Patients suspected of type 1 diabetes should be screened for other autoimmune diseases regularly. Monitoring thyroid and celiac diseases is crucial for patients with type 1 diabetes, as they are at risk for various autoimmune disorders.
Testing for complications
Patients with type 2 diabetes need further assessment. Testing for obstructive sleep apnea, polycystic ovary syndrome, and other potential complications is vital.
Testing for autoimmune diseases
References:
1. ElSayed NA, Aleppo G, Aroda VR, et al: Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 46(Suppl 1):S19-S40, 2023. doi: 10.2337/dc23-S002
2. Libman I, Haynes A, Lyons S, et al: ISPAD Clinical Practice Consensus Guidelines 2022: Definition, Epidemiology, and Classification of Diabetes in Children and Adolescents. Pediatr Diabetes 23(8):1160-1174, 2022. doi: 10.1111/pedi.13454
3. Wallace AS, Wang D, Shin JI, Selvin E: Screening and Diagnosis of Prediabetes and Diabetes in US Children and Adolescents. Pediatrics 146(3):e20200265, 2020. doi: 10.1542/peds.2020-0265
4. In the UKPDS 25 study conducted by Turner R and colleagues in 1997, the presence of autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase was examined as a predictor of insulin requirement in type 2 diabetes patients.
5. Klingensmith GJ and team reported in 2010 on the detection of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype from the TODAY study.
6. Shah AS et al. in 2022 published the ISPAD Clinical Practice Consensus Guidelines focusing on type 2 diabetes management in children and adolescents.
7. The study by Ziegler AG et al. in 2013 investigated the risk of diabetes progression in children with seroconversion to multiple islet autoantibodies.
8. Besser REJ and colleagues in 2022 provided the ISPAD Clinical Practice Consensus Guidelines on the stages of type 1 diabetes in children and adolescents.
9. ElSayed NA et al. in 2023 published the ‘Standards of Care in Diabetes-2023’ focusing on children and adolescents with diabetes.
Healthy food choices and exercise
In managing type 1 diabetes, insulin is crucial, while metformin, insulin, or GLP-1 agonists may be used for type 2 diabetes management. Intensive education and treatment during childhood and adolescence can help in reaching treatment goals, maintaining normal blood glucose levels, and preventing complications.
Lifestyle modifications include regular eating, limiting refined carbohydrates and saturated fats, and increasing physical activity. It is recommended to promote healthy meal choices and strong heart-healthy habits to improve diabetes outcomes and decrease cardiovascular risk.
Routine monitoring involves:
– Multiple daily glucose checks
– Continuous glucose monitoring
– HbA1C measurements every 3 months
Self-monitoring of blood glucose
Monitoring blood glucose levels through intermittent fingersticks is crucial, especially before meals and bedtime snacks. Adjustments should be made based on exercise, illness, and mealtime routines to achieve glycemic targets.
Continuous glucose monitoring (CGM)
CGM systems provide a close monitoring of glucose levels and can replace routine self-monitoring. These systems help in lowering HbA1C levels, increasing time-in-range, and reducing hypoglycemia risk, thus enhancing diabetes management.
In type 1 diabetes management, basal-bolus regimens and carbohydrate counting have revolutionized meal planning strategies. Insulin dosing should be individualized based on factors like age, activity level, and puberty status. Blood glucose monitoring through self-monitoring or CGM systems is essential for metabolic control and improving HbA1C levels.
It is important to monitor HbA1C levels, correlate them with time-in-range values, and make adjustments to the treatment plan for optimal diabetes management. Additional CGM metrics like average sensor glucose, time-above-range, and time-below-range also play a critical role in assessing the effectiveness of insulin therapy regimen.
Ketone testing should not be overlooked, especially during illness or high blood sugar levels, to prevent diabetic ketoacidosis. Managing hypoglycemia with fast-acting carbohydrates is essential to avoid severe consequences in children undergoing insulin therapy.
Efforts are underway to explore disease-modifying therapies like teplizumab to delay type 1 diabetes onset. Lifestyle changes emphasizing improved nutrition and physical activity are vital in managing type 2 diabetes effectively.
Weight loss, increased physical activity, and dietary modifications are recommended strategies for type 2 diabetes management. Initiation of insulin therapy in severe type 1 diabetes cases and metformin as a first-line oral medication for type 2 diabetes are common practices. Regular monitoring of HbA1C levels is crucial in adjusting treatment plans for optimal diabetes management.
Managing Fasting Glucose Levels in Type 2 Diabetes
Similar to how target fasting glucose levels are set for type 1 diabetes, patients with type 2 diabetes also have specific targets to aim for. While those with type 2 diabetes may not monitor their blood glucose levels as frequently as those with type 1 diabetes, the frequency of monitoring can vary depending on the treatment plan and other factors.
For children and teenagers with type 2 diabetes, monitoring glucose levels at least three times a day may be necessary based on their regimen and level of control. If targets are not being met or during times of illness, the frequency of monitoring should be increased.
Setting HbA1C Targets for Type 2 Diabetes in children and adolescents mirrors the targets used for type 1 diabetes. Regular monitoring is essential to ensure optimal control, and adjustments may be made for those who are only taking metformin and experiencing significant weight loss.
Individualized Management for Monogenic Diabetes
The approach to treating monogenic diabetes varies depending on the specific subtype. For instance, patients with the glucokinase subtype typically do not require treatment. Meanwhile, those with the hepatic nuclear factor 4-alpha and hepatic nuclear factor 1-alpha subtypes often respond well to sulfonylureas, with some eventually needing insulin.
Understanding and Addressing DKA in Diabetes
Diabetic ketoacidosis (DKA) is a common concern for individuals with type 1 diabetes and can have various triggers. Mental health issues play a significant role in the management of diabetes in children and can impact treatment adherence. While vascular complications are rare in childhood, regular monitoring is crucial for early detection if they do occur.